INVOLVED-NODE AND INVOLVED-FIELD VOLUMETRIC MODULATED ARC VS. FIXED BEAM INTENSITY-MODULATED RADIOTHERAPY FOR FEMALE PATIENTS WITH EARLY-STAGE SUPRA-DIAPHRAGMATIC HODGKIN LYMPHOMA: A COMPARATIVE PLANNING STUDY

被引:74
|
作者
Weber, Damien C. [1 ]
Peguret, Nicolas [1 ]
Dipasquale, Glovanna [1 ]
Cozzi, Luca [2 ]
机构
[1] Univ Geneva, Dept Radiat Oncol, Univ Hosp Geneva, CH-1211 Geneva 14, Switzerland
[2] Oncol Inst So Switzerland, Med Phys Unit, Bellinzona, Switzerland
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2009年 / 75卷 / 05期
关键词
Volumetric modulated arc therapy; IMRT; Hodgkin lymphoma; Involved node radiotherapy; Involved field radiotherapy; LONG-TERM SURVIVORS; BREAST-CANCER; RADIATION-THERAPY; HEART-DISEASE; SINGLE-ARC; RISK; CHEMOTHERAPY; CARDIOTOXICITY; GUIDELINES; REDUCTION;
D O I
10.1016/j.ijrobp.2009.05.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: A comparative treatment planning study was performed to compare volumetric-modulated arc (RA) to conventional intensity modulated (IMRT) for involved-field (IFRT) and involved-node (INRT) radiotherapy for Hodgkin lymphoma (HL). Methods and Materials: Plans for 10 early-stage HL female patients were computed for RA and IMRT. First, the planning target volume (PTV) coverage and organs at risk (OAR) dose deposition was assessed between the two modalities. Second, the OAR (lung, breast, heart, thyroid, and submandibular gland) dose-volume histograms were computed and compared for IFRT and INRT, respectively. Results: For IFRT and INRT, PTV coverage was equally homogeneous with both RA and IMRT. By and large, the OAR irradiation with IFRT planning was not significantly different between RA and IMRT. For INRT, doses computed for RA were, however, usually lower than those with IMRT, particularly so for the lung, breast, and thyroid. Regardless of RA and IMRT modalities, a significant 20-50% decrease of the OAR computed mean doses was observed with INRT when compared with IFRT (Breast D(mean) 1.5 +/- 1.1 vs. 2.6 +/- 1.7 Gy, p < 0.01 and 1.6 +/- 1.1 vs. 2.9 +/- 1.9 Gy, p < 0.01 for RA and IMRT, respectively). Conclusions: RA and IMRT results in similar level of dose homogeneity. With INRT but not IFRT planning, the computed doses to the PTV and OAR were usually higher and lower with RA when compared to IMRT. Regardless of the treatment modality, INRT when compared with IFRT planning led to a significant decrease in OAR doses, particularly so for the breast and heart. (C) 2009 Elsevier Inc.
引用
收藏
页码:1578 / 1586
页数:9
相关论文
共 10 条
  • [1] Intensity-modulated radiotherapy and involved-node concept in patients with Hodgkin lymphoma: Experience of the Gustave-Roussy Institute
    Paumier, A.
    Khodari, W.
    Beaudre, A.
    Ghalibafian, M.
    Blanchard, P.
    Al Hamokles, H.
    Bhari, M.
    Lessard, N.
    Girinsky, T.
    CANCER RADIOTHERAPIE, 2011, 15 (08): : 709 - 715
  • [2] Radiotherapy for Early Mediastinal Hodgkin Lymphoma According to the German Hodgkin Study Group (GHSG): The Roles of Intensity-Modulated Radiotherapy and Involved-Node Radiotherapy
    Koeck, Julia
    Abo-Madyan, Yasser
    Lohr, Frank
    Stieler, Florian
    Kriz, Jan
    Mueller, Rolf-Peter
    Wenz, Frederik
    Eich, Hans Theodor
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (01): : 268 - 276
  • [3] Dosimetric and Clinical Outcomes of Involved-Field Intensity-Modulated Radiotherapy After Chemotherapy for Early-Stage Hodgkin's Lymphoma With Mediastinal Involvement
    Lu, Ning-Ning
    Li, Ye-Xiong
    Wu, Run-Ye
    Zhang, Xi-Mei
    Wang, Wei-Hu
    Jin, Jing
    Song, Yong-Wen
    Fang, Hui
    Ren, Hua
    Wang, Shu-Lian
    Liu, Yue-Ping
    Liu, Xin-Fan
    Chen, Bo
    Dai, Jian-Rong
    Yu, Zi-Hao
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (01): : 210 - 216
  • [4] PREDICTED RISK OF RADIATION-INDUCED CANCERS AFTER INVOLVED FIELD AND INVOLVED NODE RADIOTHERAPY WITH OR WITHOUT INTENSITY MODULATION FOR EARLY-STAGE HODGKIN LYMPHOMA IN FEMALE PATIENTS
    Weber, Damien C.
    Johanson, Safora
    Peguret, Nicolas
    Cozzi, Luca
    Olsen, Dag R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : 490 - 497
  • [5] MILD TOXICITY AND FAVORABLE PROGNOSIS OF HIGH-DOSE AND EXTENDED INVOLVED-FIELD INTENSITY-MODULATED RADIOTHERAPY FOR PATIENTS WITH EARLY-STAGE NASAL NK/T-CELL LYMPHOMA
    Wang, Hua
    Li, Ye-Xiong
    Wang, Wei-Hu
    Jin, Jing
    Dai, Jian-Rong
    Wang, Shu-Lian
    Liu, Yue-Ping
    Song, Yong-Wen
    Wang, Zhao-Yang
    Liu, Qing-Feng
    Fang, Hui
    Qi, Shu-Nan
    Liu, Xin-Fan
    Yu, Zi-Hao
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (03): : 1115 - 1121
  • [6] Volumetric-modulated arc therapy vs conventional fixed-field intensity-Modulated radiotherapy in a whole-ventricular irradiation: A planning comparison study
    Sakanaka, Katsuyuki
    Mizowaki, Takashi
    Sato, Sayaka
    Ogura, Kengo
    Hiraoka, Masahiro
    MEDICAL DOSIMETRY, 2013, 38 (02) : 204 - 208
  • [7] A comparative dosimetric study of volumetric-modulated arc therapy vs. fixed field intensity-modulated radiotherapy in postoperative irradiation of stage IB-IIA high-risk cervical cancer
    Qiao, Lili
    Cheng, Jian
    Liang, Ning
    Xie, Jian
    Luo, Hui
    Zhang, Jiandong
    ONCOLOGY LETTERS, 2016, 11 (02) : 959 - 964
  • [8] A comparative dosimetric study of cervical cancer patients with para-aortic lymph node metastasis treated with volumetric modulated arc therapy vs. 9-field intensity-modulated radiation therapy
    Wu, Yaqin
    Zhu, Biqing
    Han, Jingjing
    Xu, Hanzi
    Gong, Zhen
    Yang, Yongqin
    Huang, Jian
    Lu, Emei
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (22)
  • [9] Volumetric-modulated arc therapy (RapidArc) vs. conventional fixed-field intensity-modulated radiotherapy for 18F-FDG-PET-guided dose escalation in oropharyngeal cancer: A planning study
    Teoh, May
    Beveridge, Sabeena
    Wood, Katie
    Whitaker, Stephen
    Adams, Elizabeth
    Rickard, Donna
    Jordan, Tom
    Nisbet, Andrew
    Clark, Catharine H.
    MEDICAL DOSIMETRY, 2013, 38 (01) : 18 - 24
  • [10] Promising clinical outcomes of sequential and "Sandwich" chemotherapy and extended involved-field intensity-modulated radiotherapy in patients with stage IE/IIE extranodal natural killer/T-cell lymphoma
    Wang, Han-yu
    Niu, Shao-qing
    Yang, Yun-ying
    Li, Yi-yang
    Chen, Hong-bo
    Zhang, Yu-jing
    CANCER MEDICINE, 2018, 7 (12): : 5863 - 5869